Heartflow, Inc. (NASDAQ:HTFL) Receives $38.60 Average PT from Brokerages

Heartflow, Inc. (NASDAQ:HTFL) has received a consensus rating of “Hold” from the seven ratings firms that are presently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year price target among analysts that have covered the stock in the last year is $38.60.

Several brokerages have recently issued reports on HTFL. Canaccord Genuity Group raised their price target on Heartflow from $39.00 to $40.00 and gave the company a “buy” rating in a research report on Thursday, November 13th. Stifel Nicolaus raised their target price on Heartflow from $35.00 to $40.00 and gave the company a “buy” rating in a report on Thursday, November 13th. Weiss Ratings reiterated a “sell (d)” rating on shares of Heartflow in a report on Monday, December 29th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Heartflow from $36.00 to $40.00 and gave the stock an “overweight” rating in a research note on Thursday, November 13th.

Heartflow Trading Up 4.5%

NASDAQ HTFL opened at $32.58 on Monday. Heartflow has a 1 year low of $25.38 and a 1 year high of $41.22. The business’s fifty day moving average price is $30.36. The company has a market cap of $2.77 billion and a P/E ratio of -18.00.

Insider Activity

In related news, Director Jeffrey C. Lightcap acquired 40,000 shares of the business’s stock in a transaction dated Tuesday, December 16th. The stock was acquired at an average price of $26.34 per share, with a total value of $1,053,600.00. Following the completion of the transaction, the director owned 40,000 shares of the company’s stock, valued at approximately $1,053,600. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Hedge Funds Weigh In On Heartflow

Several large investors have recently added to or reduced their stakes in the company. TFC Financial Management Inc. acquired a new stake in shares of Heartflow during the 3rd quarter worth approximately $40,000. Legal & General Group Plc bought a new position in Heartflow in the third quarter worth $59,000. Y Intercept Hong Kong Ltd acquired a new stake in Heartflow during the third quarter worth $234,000. Legato Capital Management LLC bought a new stake in Heartflow in the 3rd quarter valued at $243,000. Finally, Sandia Investment Management LP bought a new position in shares of Heartflow during the 3rd quarter worth about $252,000.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.